AstraZeneca will migrate its existing enterprise resource planning (ERP) systems to German multinational software company SAP's Cloud ERP Private through RISE with SAP, expanding the pair's 20-year relationship.
SAP said the full-estate migration "extends one of the largest SAP footprints in life sciences," with AstraZeneca aiming to connect processes and data across its business.
Through its Axial Business Transformation Programme, AstraZeneca is moving from legacy SAP ERP Central Component environments to SAP Cloud ERP Private, addressing issues such as data silos, inefficient processes and slow decision-making.
This should make it easier for AstraZeneca to operate globally, respond to changes and introduce new technologies.
“SAP has been a key part of how we run our operations for more than two decades,” Chris Taylor, Chief Information Officer, AstraZeneca, said.
Through Axial, we are simplifying how AstraZeneca operates and creating the foundations to move faster and unlock greater value from AI.
"That matters because the faster we can turn insight into action, the faster we can create value for our company and for patients.”
AstraZeneca added that it is exploring SAP's Business AI capabilities, including AI applications and agentic use cases across manufacturing, finance and supply chain.
The announcement also said AstraZeneca will use SAP's Green Ledger solution, designed to connect financial and sustainability data and help businesses incorporate environmental considerations into financial and operational decision-making.
“Across the life sciences and healthcare industry, companies are rethinking how technology can help them manage complexity and drive greater value,” Thomas Saueressig, Chief Customer Officer and Member of the Executive Board of SAP SE, said.
"AstraZeneca’s Axial Transformation Programme shows how cloud, data and AI can create a stronger foundation for innovation at scale."
By helping simplify operations, enable faster decisions and unlock trusted insights, we can support AstraZeneca as it works to push the boundaries of science to deliver life-changing medicines to patients worldwide.
